Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective study of ondansetron for prevention of postoperative nausea and vomiting after laparoscopic surgery under general anesthesia
ChiCTR2500105784Phase 4Not yet recruiting
- Sponsor
- Dalian Third People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Dalian Third People's Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting on postoperative day 1. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500105784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105784.